Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype

The problem of fibrosing interstitial lung diseases (ILDs) unites specialists from different areas: pulmonologists, radiologists, therapists, rheumatologists, occupational doctors and others. Actual achievements in studying fibrosing ILDs which are connected with development of immunology and molecu...

Full description

Saved in:
Bibliographic Details
Main Authors: L. P. Ananieva, S. N. Avdeev, I. Е. Tyurin, A. М. Lila, A. I. Zagrebneva, А. L. Maslyanskiy, S. A. Terpigorev, I. V. Stepanyan, E. L. Lashina, O. V. Vasilieva, O. S. Lukina, E S. Pershina, А. А. Klimenko, N. A. Shostak, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2021-01-01
Series:Научно-практическая ревматология
Subjects:
interstitial lung diseases
immune-inflammatory rheumatic diseases
antifibrotic therapy
nintedanib
Online Access:https://rsp.mediar-press.net/rsp/article/view/2960
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The problem of fibrosing interstitial lung diseases (ILDs) unites specialists from different areas: pulmonologists, radiologists, therapists, rheumatologists, occupational doctors and others. Actual achievements in studying fibrosing ILDs which are connected with development of immunology and molecular biological methods for the determination of biomarkers, new principles of image-diagnostics of lung pathology, search of new therapeutic “targets”, dictate the necessity of integration of knowledge by specialists from different areas of medicine for improvement pharmacotherapy algorithms. These algorithms directed to decrease fibrosis progression in ILDs, improve quality and increase lifespan of the patients.
ISSN:1995-4484
1995-4492

Similar Items